News

California Proposes Adding Atrazine to the Proposition 65 Cancer List 

California’s Office of Environmental Health Hazard Assessment (OEHHA) announced on October 9, 2026, its intention to list atrazine (CAS No. 1912-24-9) as a chemical known to the State of California to cause cancer under Proposition 65. 

The proposal follows an assessment by the International Agency for Research on Cancer (IARC), which classified atrazine as Group 2A – Probably Carcinogenic to Humans. 

Importantly, atrazine is already listed under Proposition 65 for developmental toxicity and female reproductive toxicity, effective July 15, 2016. The new proposal would add cancer as an additional basis for listing rather than introduce atrazine to the Proposition 65 list for the first time. 

OEHHA has opened a public comment period, with submissions accepted until November 9, 2026. 

The proposed cancer listing could have implications for chemical manufacturers, importers, distributors, agricultural businesses and other companies involved in activities that may result in atrazine exposure in California. 

What Is Atrazine and Where Is It Used? 

Atrazine is a herbicide belonging to the triazine chemical family. 

It is widely used in agricultural weed control, particularly in the cultivation of corn, sugarcane and certain other crops. 

Atrazine is designed to control a range of broadleaf and grassy weeds. 

Due to its agricultural applications and potential transport through the environment, the substance has been the subject of ongoing scientific and regulatory assessments. 

Key areas of concern include: 

  • Occupational exposure during agricultural use. 
  • Potential contamination of surface water and groundwater. 
  • Environmental persistence and degradation products. 
  • Potential effects on reproductive health. 
  • Scientific evidence relating to carcinogenicity. 

These considerations make atrazine relevant to both pesticide regulation and broader chemical safety legislation. 

Why Is OEHHA Proposing to List Atrazine as a Carcinogen? 

OEHHA’s proposal is based on the carcinogenic hazard classification established by the International Agency for Research on Cancer. 

IARC has classified atrazine as Group 2A, Probably Carcinogenic to Humans. 

This classification is based on an evaluation of the available scientific evidence concerning the substance’s carcinogenic potential. 

What Does IARC Group 2A Mean? 

IARC Group 2A identifies agents considered probably carcinogenic to humans. 

The classification may be supported by evidence from human studies, experimental animal studies and mechanistic investigations. 

For atrazine, IARC considered limited evidence of carcinogenicity in humans together with sufficient evidence in experimental animals and relevant mechanistic evidence. 

The classification addresses the potential of the chemical to cause cancer, rather than providing a quantitative estimate of cancer risk at a particular exposure level. 

This distinction is important when interpreting the proposed Proposition 65 listing and its potential implications for businesses. 

Is Atrazine Already Listed Under California Proposition 65? 

Yes. Atrazine has been listed under Proposition 65 since July 15, 2016, for two reproductive toxicity endpoints: 

  • Developmental toxicity. 
  • Female reproductive toxicity. 

The October 2026 proposal does not remove or replace these existing classifications. 

Instead, OEHHA intends to add cancer as an additional endpoint. 

This means that companies should consider both the existing reproductive toxicity listing and the potential consequences of an additional cancer classification. 

Existing Proposition 65 obligations relating to reproductive toxicity may already apply to relevant exposures. 

What Is California Proposition 65? 

The Safe Drinking Water and Toxic Enforcement Act of 1986, commonly known as California Proposition 65, establishes requirements concerning exposure to chemicals known to the State of California to cause cancer, birth defects or other reproductive harm. 

The law includes two principal mechanisms. 

1. Exposure Warning Requirements 

Businesses operating in California may be required to provide clear and reasonable warnings before knowingly and intentionally exposing individuals to listed chemicals. 

Warnings may be required unless an applicable exemption or risk-based exception applies. 

Depending on the exposure scenario, warnings may be provided through product labels, workplace signs, notices or other legally appropriate communication methods. 

The mere presence of a listed chemical in a product does not automatically mean that a warning is required. The relevant exposure and applicable regulatory provisions must also be evaluated. 

2. Drinking Water Discharge Restrictions 

Proposition 65 also prohibits certain knowing discharges or releases of listed chemicals into sources of drinking water. 

Companies must assess whether their activities create relevant releases and whether statutory exceptions apply. 

These requirements are separate from other pesticide, environmental and workplace safety obligations. 

How Does the Proposition 65 Listing Process Work? 

OEHHA is proposing the cancer listing through the Labor Code listing mechanism. 

Under this mechanism, certain scientific classifications established by IARC can provide a basis for adding chemicals to the Proposition 65 list. 

The process involves: 

  1. Identification of the relevant carcinogenicity classification. 
  1. Evaluation of whether the substance meets the legal criteria for listing. 
  1. Publication of the notice of intent to list. 
  1. A public comment period addressing the applicable listing criteria. 
  1. Review of relevant comments and completion of the listing process. 

The October 9, 2026 notice initiates a public comment period that closes on November 9, 2026. 

The proposal should not be interpreted as confirmation that cancer has already been added as a final listing endpoint. 

Public Comment Deadline: November 9, 2026 

OEHHA is accepting comments on the proposed atrazine cancer listing until Monday, November 9, 2026. 

However, the scope of the consultation is limited. 

Comments should address whether IARC has sufficiently identified atrazine as a human or animal carcinogen under the applicable Proposition 65 listing criteria. 

OEHHA has clarified that, under the Labor Code mechanism, it cannot reconsider scientific arguments concerning the weight or quality of the evidence previously evaluated by IARC. 

As a result, the consultation does not constitute a new comprehensive assessment of all available carcinogenicity studies. 

Interested parties can submit comments through OEHHA’s official public consultation system. 

What Would the Proposed Cancer Listing Mean for Businesses? 

If atrazine is officially listed as a carcinogen, companies operating in or supplying products to California may need to reassess their Proposition 65 compliance programmes. 

Cancer Warning Requirements 

For a newly listed carcinogenic endpoint, the applicable warning requirements generally become enforceable 12 months after the official listing date. 

Businesses may need to evaluate whether relevant exposure scenarios require cancer warnings. 

Depending on the circumstances, this could affect: 

  • Consumer product warnings. 
  • Workplace hazard communication. 
  • Environmental exposure notices. 
  • Relevant product and distribution documentation. 

Because atrazine is already listed for reproductive toxicity, companies should also consider their existing warning obligations. 

Drinking Water Protection 

Under Proposition 65, the drinking water discharge prohibition generally becomes applicable to newly listed chemicals 20 months after listing. 

However, atrazine has already been listed for reproductive toxicity since 2016. 

Therefore, its existing listing and associated obligations must be taken into account. 

A new cancer listing should not be interpreted as creating the first drinking water protection obligations for atrazine. 

Proposition 65 Safe Harbor Levels and Exposure Assessment 

Proposition 65 uses risk-based exposure thresholds to help determine whether warning requirements apply. 

Two important concepts are: 

No Significant Risk Level (NSRL): A risk-based exposure level associated with cancer. 

Maximum Allowable Dose Level (MADL): An exposure level relevant to chemicals listed for reproductive toxicity. 

OEHHA has established safe harbor levels for many, but not all, listed substances. 

The absence of an established safe harbor level does not automatically mean that every exposure requires a warning. 

Businesses may need to conduct appropriate exposure and risk assessments in accordance with the applicable legal framework. 

For atrazine, companies should distinguish between existing reproductive toxicity obligations and any additional cancer-related requirements that may follow an official listing. 

Does Proposition 65 Listing Ban the Use of Atrazine? 

A Proposition 65 listing does not automatically prohibit the sale or use of a chemical in California. 

The legislation primarily establishes exposure warning obligations and restrictions concerning discharges into drinking water sources. 

Atrazine, as a pesticide active ingredient, is also subject to separate federal and state pesticide regulatory requirements. 

Businesses must therefore evaluate Proposition 65 compliance alongside the other laws applicable to the manufacture, distribution, sale and use of atrazine-containing products. 

How Should Companies Prepare for a Potential Atrazine Cancer Listing? 

Companies involved in manufacturing, importing, distributing or using atrazine should consider reviewing their existing chemical compliance procedures. 

Recommended actions include: 

1. Review Chemical Inventories 

Identify products, raw materials and operations involving atrazine. 

2. Verify Existing Proposition 65 Obligations 

Review current compliance requirements related to the 2016 reproductive toxicity listing. 

3. Assess Exposure Scenarios 

Evaluate potential occupational, consumer and environmental exposures associated with relevant products and activities. 

4. Review Product Warnings and Labels 

Determine whether existing warnings would require reassessment if cancer is added as an additional listing endpoint. 

5. Evaluate Drinking Water Protection Measures 

Review relevant chemical releases, wastewater management procedures and applicable discharge restrictions. 

6. Strengthen Supply Chain Communication 

Ensure that suppliers, distributors and customers receive accurate regulatory information where necessary. 

7. Monitor OEHHA’s Final Decision 

Follow the outcome of the consultation and any subsequent official listing announcement. 

These measures can help businesses identify compliance gaps and prepare for potential additional obligations. 

What Does California’s Proposed Atrazine Cancer Listing Mean? 

OEHHA’s announcement of October 9, 2026 represents a significant development in the regulatory assessment of atrazine under California Proposition 65. 

Based on IARC’s Group 2A carcinogenicity classification, the proposal would add cancer as an additional endpoint to atrazine’s existing Proposition 65 listing. 

Atrazine has already been listed for developmental toxicity and female reproductive toxicity since July 2016, meaning that relevant compliance obligations may already apply. 

If the proposed cancer listing is finalised, companies may need to reassess exposure warnings, risk management measures and related documentation. 

Manufacturers, importers, distributors and businesses supplying the California market should monitor OEHHA’s final decision and evaluate both existing reproductive toxicity requirements and potential additional cancer-related obligations. 

The public comment period remains open until November 9, 2026.